Hepatitis C virus inhibitors
US7041698B2 · kind B2 · utility
65Cited by
12References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2003 |
| Grant date | May 9, 2006 |
| Priority date | — |
| Expiry date | Mar 11, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0823
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.